Events
Nov 23, 2021

Interview:Brain measurement goes mainstream

Have you ever wondered what the most pressing themes, such as climate change, the notion of conflict and terrorism, social people, and automation, have in common?

The answer is hidden in our brains. The way we tick, make decisions, and act is all coded in our brains. 

Bryan Johnson and his LA team at Kernel are on a mission to finally measure and understand the way we use our brains. How? It is done through a state-of-the-art technical device that helps us better understand ourselves and the changes and responses that are happening in our brains. 

Kernel is already paving the path towards a future where we can effectively personalize mental health treatments – and so much more. 

During Reflect Festival, Vestberry CEO, Marek  Zamecnik, quizzed Bryan about the ins and outs of his discovery and which psychedelic drug he is using for testing. 

Watch the interview

Author

Vestberry

Vestberry is building a fintech analytical platform helping Venture Capital and Private Equity investors manage their capital smarter, allowing them to invest in companies who strive to solve the world’s most pressing challenges, from climate change to mental health. With Vestberry, our clients increase team productivity significantly, streamline internal processes, and can make better investment decisions faster. As a result, Vestberry brings clients a competitive advantage, both in terms of speed & quality of investment decisions and also the potential to attract increasingly data-oriented investors.

Related Articles

Company Updates
Mar 27, 2023

Mouro Capital joins forces with Vestberry for 3.0 lean portfolio management

Welcome Mouro Capital, a venture capital firm that invests in the future of financial services. With $400 million in assets under ...

Industry Insights
Mar 15, 2023

VC tech stack – Data visualization for better insight sharing among GPs and LPs

One of the most important aspects of data analytics in venture capital is the ability to share insights effectively with both Gene...